Abatacept: a new treatment option for refractory adult autoimmune enteropathy.
about
Seronegative Adult Autoimmune Enteropathy in a Male Traveler.The biopsy pathology of non-coeliac enteropathy.Increased Risk for Malignancies in 131 Affected Mutation CarriersCytotoxic T-Lymphocyte-Associated Protein 4 Haploinsufficiency-Associated Inflammation Can Occur Independently of T-Cell Hyperproliferation
P2860
Abatacept: a new treatment option for refractory adult autoimmune enteropathy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Abatacept: a new treatment option for refractory adult autoimmune enteropathy.
@ast
Abatacept: a new treatment option for refractory adult autoimmune enteropathy.
@en
type
label
Abatacept: a new treatment option for refractory adult autoimmune enteropathy.
@ast
Abatacept: a new treatment option for refractory adult autoimmune enteropathy.
@en
prefLabel
Abatacept: a new treatment option for refractory adult autoimmune enteropathy.
@ast
Abatacept: a new treatment option for refractory adult autoimmune enteropathy.
@en
P2093
P2860
P1476
Abatacept: a new treatment option for refractory adult autoimmune enteropathy.
@en
P2093
Mark Fisher
Omer Yilmaz
Vijay Yajnik
P2860
P356
10.1097/MCG.0B013E3182A4E0EC
P577
2014-01-01T00:00:00Z